Siemens Healthineers announces FDA clearance of MAMMOMAT Revelation mammography system

The FDA has cleared MAMMOMAT Revelation, a premium mammography platform from Siemens Healthineers with the new InSpect integrated specimen imaging tool and the new HD breast biopsy solution for one-click targeting of suspicious areas. These and other features are designed to expand precision medicine and improve the patient experience.

Mammography utilization declined due to revised USPSTF breast cancer screening guidelines

Screening mammography utilization dropped in 2010 after years of growth, according to a new study published in the American Journal of Roentgenology. The decline in utilization, the authors noted, seems to have been brought on by revised breast cancer screening guidelines released by the U.S. Preventive Services Task Force (USPSTF) in 2009.

Inflammation Testing Prompts Care Changes Leading to Significantly Lower Levels in Patients with Increased Cardiovascular Risk Due to Diabetes or Pre-Diabetes

BOCA RATON, Fla., March 27, 2018 — New research from MDVIP and Cleveland HeartLab finds that patients with diabetes, pre-diabetes or no evidence of diabetes whose physicians ordered myeloperoxidase (MPO) inflammation testing achieved sharp reductions in MPO levels over five years.